Trial intelligence / Profile preview

MMF vs Tacrolimus in Membranous Lupus Nephritis

NCT00404794Phase 3Completed

Sponsor
Hospital Authority
Start
Nov 2005
Modality
RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 3 trial of mycophenolate mofetil, tacrolimus in lupus membranous nephropathy (LMN), sponsored by Hospital Authority. Started Nov 2005; status: completed.

02

Drugs

mycophenolate mofetiltacrolimus
03

Conditions

lupus membranous nephropathy (LMN)

Beyond the preview

Go deeper on NCT00404794.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00404794.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call